New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Late Stage Cancer

June 19, 2020 by Fightec.org

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer.

https://www.survivornet.com/articles/new-hope-for-esophageal-cancer-patients-immunotherapy-opdivo-approved-for-treatment-of-advanced-esophageal-cancer/